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ABSTRACT
Introduction Patients with cancer undergoing surgery 
often suffer from reduced quality of life and various forms 
of distress. Untreated distress can negatively affect coping 
resources as well as surgical and oncological outcomes. 
A virtual reality- based stress reduction intervention 
may increase quality of life and well- being and reduce 
distress in the perioperative phase for patients with 
cancer. This pilot trial aims to explore the feasibility of the 
proposed intervention, assess patient acceptability and 
obtain estimates of effect to provide data for sample size 
calculations.
Methods and analysis Patients with colorectal cancer 
and liver metastasis undergoing elective surgery will be 
recruited for this single- centre, randomised pilot trial 
with a three- arm design. A total of 54 participants will 
be randomised at 1:1:1 ratio to one of two intervention 
groups or a control receiving standard treatment. Those 
randomised to an intervention group will either receive 
perioperative virtual reality- based stress reduction 
exercises twice daily or listen to classical music twice 
daily. Primary feasibility outcomes are number and 
proportions of participants recruited, screened, consented 
and randomised. Furthermore, adherence to the 
intervention, compliance with the completion of the quality 
of life questionnaires and feasibility of implementing 
the trial procedures will be assessed. Secondary clinical 
outcomes are measurements of the effectiveness of the 
interventions to inform sample size calculations.
Ethics and dissemination The study protocol, the 
patient information and the informed consent form have 
been approved by the ethics committee of the Ludwigs- 
Maximilians- University, Munich, Germany (Reference 
Number: 19–915). Study findings will be submitted for 
publication in peer- reviewed journals.
Trial registration number DRKS00020909.
INTRODUCTION
Perioperative psychosocial issues and quality of 
life
The diagnosis of cancer is a heavy burden for 
patients and can cause a significant level of 
psychological distress.1–3 Distress in patients 
with cancer is defined as a ‘multifactorial 
unpleasant experience of a psychological, 
social, spiritual and/or physical nature that 
may interfere with the ability to cope effec-
tively with cancer, its physical symptoms, and 
its treatment’.2 Patients with cancer under-
going surgery often suffer from distress in 
the perioperative phase.4 5 The observed 
prevalence of distress is 25%–50% in patients 
with cancer, and it has been reported that 
in a general surgery population, about one- 
third of patients suffer from anxiety and 
half suffer from depression.2 5–7 Distress can 
manifest itself in a wide range of symptoms 
from normal feelings of sadness and fear to 
depressive episodes, sleep disorders, reduced 
quality of life, anxiety disorders and existen-
tial crisis in severe cases.1 2 4 The presence of 
coexisting psychiatric issues such as distress, 
anxiety and depression can negatively influ-
ence a patient’s coping resources, surgical 
Strengths and limitations of this study
 ► This pilot trial will assess the feasibility of the trial 
design and protocol as well as patient compliance 
and patient acceptance of a virtual reality- based 
stress reduction intervention.
 ► Using the QLQ- C30 questionnaire with additional 
items will increase measurement precision for core 
quality of life domains.
 ► The virtual reality- based stress reduction interven-
tion is non- invasive and aims at increasing well- 
being and quality of life in patients with cancer.
 ► The use of a randomised three- arm design will re-
duce potential bias.
 ► Implementation of the stress reduction intervention 
in a general surgery population might be more com-
plicated compared with other cancer patient pop-
ulations and might influence feasibility and clinical 
outcomes.
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and oncological outcomes.8–12 Untreated preopera-
tive distress was associated with reduced well- being and 
quality of life 2 years after surgery.4 13 In the perioperative 
setting, the unfamiliar hospital environment, the large 
number of documents to be signed, the work processes 
that are difficult to understand for the patient and the 
short contact with constantly changing hospital staff can 
further unsettle patients who are already burdened by 
their diagnosis and upcoming examinations and opera-
tions.14 15
The European Organisation for Research and Treat-
ment of Cancer (EORTC) evaluated quality of life data for 
over 23 000 patients with cancer using the Quality of Life 
Questionnaire Core 30 (QLQ- C30).16 17 Four items (worry, 
tension, irritability and depression) of the QLQ- C30 are 
combined into the ‘emotional functioning’ (EF) scale 
(scored on a 0–100 points scale, higher values correspond 
to a lower burden). A score below 70 is regarded as a clin-
ically relevant burden and for patients with colorectal 
cancer (CRC), the EF scale averaged 68 points.17 18 Based 
on EORTC data, 47% of patients with colorectal cancer 
have an EF scale score below 70.17
Additionally, fatigue and sleep disturbances are symp-
toms frequently reported by patients with cancer.17 19–21 
Three items (feeling tired, weakness and need to rest) 
are combined into the ‘fatigue’ (FA) scale (0–100 points, 
lower values correspond to a lower burden) of the QLQ- 
C30. A score above 39 indicates a clinically relevant 
burden in the FA scale.18 About 37% of patients with CRC 
have an FA subscale score above that threshold. Addi-
tionally, 27% of patients with CRC suffer from severe or 
moderate sleep disturbances.17
Stress reduction and clinical use of virtual reality (VR)
Various forms of stress reduction for patients in the periop-
erative period have been studied. Renzi et al22 showed that 
proctologic patients who experienced relaxing music and 
lyrics before, during and after the procedure had signifi-
cantly better sleep quality and showed a trend towards 
less postoperative pain. Studies suggest that perioper-
ative stress reduction has a positive effect on quality of 
life and possibly positive immunological effects.23 These 
immunological effects manifest themselves, for example, 
in improved wound healing.23 24 Preoperative reduction 
of psychological stress is also part of a larger concept 
known as prehabilitation with the goal of increasing phys-
iological reserves in anticipation of surgery, improving 
adherence and outcomes.25 Prehabilitation programmes 
consisting of physical training, nutritional adjustment 
and stress reduction interventions have shown to improve 
postoperative exercise capacity in certain patients with 
CRC.26 Technological progress has widened the spectrum 
of potential tools for stress reduction. VR is an immer-
sive and interactive technology that visually, acousti-
cally and haptically simulates a virtual environment and 
evokes a sense of presence in that environment.27–29 The 
sense of presence that is often defined as the sensation 
of being in the virtual scene is created by realism of the 
graphics and by the potential of a VR experience to elicit 
emotional responses.30 31 VR is being explored in various 
clinical settings and has attracted much attention as a 
cost- effective intervention, especially in psychiatry.32 A 
recent meta- analysis has shown that VR- based treatments 
lead to significant improvements in anxiety disorders and 
depression.33 VR interventions have been successfully 
used in children and adults for the treatment of acute 
and peri- interventional pain and has shown usefulness 
in addressing psychological well- being in children and 
adolescents with cancer.28 34–36 Virtual environments, 
especially those with a high degree of immersion, create 
a strong distraction from the real environment or painful 
procedures because the patient cannot see his immediate 
surroundings through the VR headset, and a sense of 
presence in VR environment is evoked.29 37 In addition, 
there may be active patient interaction with the VR envi-
ronment, which adds to the distraction.36 VR systems have 
shown the ability to produce positive emotional experi-
ences, and evidence is emerging that VR technology 
can increase emotional, psychological and social well- 
being.30 38 Based on these findings, VR- based interven-
tions could be used for perioperative stress reduction and 
relaxation that might improve various aspects of quality 
of life, perioperative sleep, well- being and patient satis-
faction in cancer patients undergoing major abdominal 
surgery.
Rationale for a pilot trial
Currently, little is known about the feasibility and accep-
tance of VR- based stress reduction interventions in 
patients with cancer. There is no existing data that can be 
used to estimate the size of the effect and thus to enable a 
high- quality sample size calculation. Therefore, this pilot 
trial aims to explore the feasibility of the proposed inter-
vention and to assess whether the design and protocol 
used are feasible in terms of patient recruitment, patient 
compliance and patient acceptance of the intervention. 
The second goal is to obtain estimates of the effect on 
quality of life, sleep, patient satisfaction and surgical 
outcome to provide data for sample size calculations.
METHODS
Trial design and study population
This pilot trial features a single- centre, randomised, 
three- arm design with a 1:1:1 allocation. The design is 
displayed in the trial flow chart (figure 1). Patients under-
going elective abdominal surgery for colorectal cancer 
or liver metastases of colorectal cancer will be recruited. 
Participants will be randomised to one of two interven-
tion groups or a control group that receives the standard 
treatment. Those randomised to an intervention group 
will either receive a preoperative and postoperative 
VR- based stress reduction interventions or a music- based 
stress reduction intervention.
Informed consent
All participants are required to provide informed written 
consent. Consent for study participation and data 
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collection will be obtained at least 1 day before surgery by 
physicians of the University Hospital Augsburg.
Eligibility criteria
 ► Aged 18–75 years.
 ► Elective abdominal surgery for colorectal cancer or 
liver metastases of colorectal cancer.
Exclusion criteria
The decision to exclude patients with certain pre- existing 
medical conditions is based on general safety recommen-
dations for VR headsets.
 ► Non- consentable patients (such as patients who are 
unable to provide informed consent or patients under 
legal guardianship).
 ► Underage patients.
 ► Pregnant patients.
 ► Patients admitted as an emergency.
 ► Participation in another clinical study that may have a 
potential impact on the endpoints of this study.
 ► Patients with a medical history of dementia, schizo-
phrenia, hallucinations, panic attacks and epileptic 
seizures.
 ► Patients who carry a pacemaker or defibrillator device.
 ► Patients taking neuroleptic or antiepileptic drugs.
 ► Patients with active alcohol and/or substance abuse.
 ► Lack of German or English language skills.
Secondary exclusion criteria and adverse events
A new diagnosis of any of the conditions listed under 
exclusion criteria will result in exclusion from the VR or 
music group. The new beginning or continued use of any 
of the medications mentioned under exclusion criteria 
Figure 1 Trial flow chart. QoL quality of life, QLQ- C30 Quality of Life Questionnaire Core 30, SF-2 Short Form 002  on M
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will result in exclusion from the VR or music group. In 
case patients are readmitted to the intensive care unit 
or experience postoperative delirium, reduced vigilance 
or physical inability to sit in bed for 10 min, the VR and 
music interventions are not performed.
The exclusion criteria and secondary exclusion criteria 
reflect the fact that VR headsets could potentially cause 
seizures, blurred vision, dizziness, light- headedness, 
nausea and other symptoms. All interventions are 
performed under direct supervision with participants 
sitting on a chair or in bed to ensure safety for trial partic-
ipants. In case trial participants experience a symptom or 
event that could be related to the intervention, the session 
will be stopped immediately, and no further sessions will 
be carried out. Any adverse event or unintended effect of 
the trial interventions will be documented and assessed.
Randomisation
Participants will be randomised by block randomisation 
with the aim to reduce a selection bias and to ensure equal 
group sizes. The size of the blocks will be made public 
after the end of the study in order to prevent prediction 
of group allocation. The randomisation is done by staff 
who is not involved in the data collection, data analysis 
or supervision of the study patients and is carried out by 
picking a sealed opaque envelope.
Blinding
Blinding of patients and staff supervising the study inter-
ventions does not take place due to the nature of the inter-
ventions. However, the physicians involved in the surgical 
treatment of the patients are blinded to the intervention.
Sample size estimation
A formal sample size calculation was not performed as 
there are no data that could serve as a foundation for a 
formal sample size calculation. For pilot studies with an 
expected medium standardised effect size, a case number 
of 15 per group has been recommended for a later 
study with a power of 90%.39 Therefore, we have chosen 
to recruit 15 patients plus an additional three patients 
(20%) per group to compensate for incomplete question-




For the intervention in the VR group, a commercially 
available standalone VR headset (Oculus Go for Busi-
ness) with external headphones and commercially avail-
able meditation software TRIPP developed by TRIPP Inc 
(TRIPP Inc, Los Angeles, California, USA) is used. The 
headset features a 5.5″ fast- switching LCD at a 2560×1440 
resolution (1280×1440 per eye). Two different VR expe-
riences are presented to each patient in the VR group 
every day from Monday to Friday. Two sessions per day 
(morning and evening) will be held. The exercises start 
on the day of admission for patients admitted before their 
surgery. Patients admitted on the day of surgery will only 
have a preoperative session if the patient is operated in 
the afternoon of the admission day. The last preoperative 
session will be on the evening before the operation for 
all patients undergoing surgery in the morning and in 
the morning on the day of the operation for all patients 
who undergo surgery in the afternoon. The first post-
operative session will take place on the first postopera-
tive day or as soon as the patient is transferred from the 
intensive care unit (ICU) to a regular ward. The sessions 
are held until the patient is discharged from hospital. 
During the intervention, patients will sit in a chair or 
in a hospital bed depending on patient condition and 
preference. The immersive VR experiences are medita-
tive and designed to produce a calming effect. The VR 
environment is updated daily to encourage ongoing 
engagement. Despite the daily changing environment, 
the morning and evening sessions consist of recurring 
components that are part of every session. The morning 
VR experience, which lasts 7–8 min, has four levels incor-
porating binaural audio, procedurally generated music, 
guided reflections, breathing exercises with breath visual-
isation and a mini- game, all designed to focus attention. 
The audio is delivered through headphones worn by the 
patient. The patient is guided through the experience 
by a narrator. The instructions are in English. Patients 
with insufficient knowledge of English will be instructed 
in German by an employee of the University Hospital 
Augsburg who is simultaneously listening to the VR expe-
rience. The evening VR session is designed to produce 
a more calming effect and consists of three levels. The 
guided meditation content is more expansive than in the 
morning session. Two out of the three levels incorporate 
interactive breathing exercises with breath visualisation. 
The evening sessions last 10 min but can be adjusted to 
last longer, if the patient desires. Before and after the 
intervention, heart rate and blood pressure are measured.
Music group
In the music group, each participant listens to soothing 
classical music through headphones for 7–10 min twice 
a day from Monday to Friday. Patients will be wearing a 
VR headset, which is switched off. The exercises start on 
the day of admission for patients admitted before their 
surgery. Patients admitted on the day of surgery will only 
have a preoperative session if the patient is operated in 
the afternoon of the admission day. The last preoperative 
session will be on the evening before the operation for all 
patients undergoing surgery in the morning and in the 
morning on the day of the operation for all patients who 
undergo surgery in the afternoon. The first postoperative 
session will take place on the first postoperative day or 
as soon as the patient is transferred from the ICU to a 
regular ward. The sessions are held until the patient is 
discharged from hospital. Before and after the interven-
tion, heart rate and blood pressure are measured.
Control group
There is no intervention in the control group.
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Quality of life assessment
The assessment of quality of life in this study will be 
performed with the QLQ- C30,16 a valid and widely 
used questionnaire in patients with cancer. To improve 
measurement precision, we included additional items 
selected from the EORTC computerised adaptive testing 
(CAT) core item banks (a collection of question data-
bases) to form so- called short forms.40 Ten additional 
items were included for the measurement of ‘sleepless-
ness’ (three items), ‘fatigue’ (three items) and ‘emotional 
functioning’ (four items), following recommendations 
of the EORTC. The 10 additional items are summarised 
in the questionnaire EORTC short form 002 (SF2). 
Items were added based on our demographic data and 
based on the study’s objectives. The quality of life will be 
assessed preoperatively before the first intervention, on 
the 7th and 14th postoperative day and at discharge using 
the QLQ- C30 and EORTC- SF2 (figure 1). At discharge, 
all patients will receive additional questions regarding 
patient satisfaction.
Assessment of mood and emotions
In order to assess immediate effects of the VR and music 
interventions, each patient will receive a questionnaire 
consisting of two questions concerning the current 
emotional state and mood immediately before and after 
each intervention (online supplemental file 1).
Outcomes
Primary feasibility outcomes
 ► Participation, recruitment and retention rates. 
Participation rate is the proportion of participants 
providing consent of those who meet the inclusion 
criteria. Recruitment rate is the number of partic-
ipants recruited per month. Retention rate is the 
number of participants who complete the full number 
of planned interventions.
 ► Intervention adherence. Adherence is the proportion 
of planned interventions that have been completed by 
each participant.
 ► Patient compliance with completion of question-
naires. Compliance with completion of question-
naires is the proportion of completed questionnaires 
at the prespecified dates.
 ► Adverse events. The frequency (number of partic-
ipants and number of cases) and nature (eg, dizzi-
ness, vertigo and motion sickness) and severity will be 
recorded. Participants experiencing adverse events 
will be managed by the research team.
 ► Deviations from study protocol. Number of deviations 
from study protocol (such as skipped interventions) 
and reason for deviation from study protocol (patient 
related, staff related and organisational).
Clinical outcomes
 ► Change of mood and well- being before and after 
intervention.
 ► Change of vital signs such as heart rate, breathing 
rate, blood pressure before and after the interven-
tion. Heart rate, breathing rate and blood pres-
sure are measured manually before and after each 
intervention.
 ► Difference in change of vital signs between the music 
and VR group. Changes in vital signs before and after 
the intervention will be compared between the music 
and the VR group.
 ► Change in quality of life during the hospital stay. 
Quality of life is measured at predefined dates for each 
patient. Score and SD in the quality of life question-
naire, as well as the score and SD in all subscales, in 
particular emotional functioning, sleep and fatigue, 
are compared.
 ► Difference in quality of life between the three study 
groups. Score and SD in the quality of life question-
naire are compared between all three study groups.
 ► Difference in number and severity of surgical compli-
cations between the three study groups.
 ► Difference in length of hospital stay between the three 
study groups.
Data collection and management
Paper- based case report forms are used for documenta-
tion of patient- related data and clinical variables including 
vital signs before and after the intervention, age, ECOG 
status, body mass index, postoperative complications, 
comorbidities, tumour stage and length of hospital stay. 
Quality of life data are collected using paper- based version 
of the QLQ- C30, which has been customised in accor-
dance with the EORTC to fit the specific needs of this 
study. All patient- related data are collected and analysed 
in pseudonymised form. For this purpose, each partici-
pant will be assigned a randomly generated numeric four- 
digit code on receipt of the written consent to participate 
in the study.
All data collected in accordance with the study protocol 
are manually transferred from the case report forms to 
an electronic SPSS database sheet (SPSS® for Windows®, 
Version 24, IBM, Armonk, New York, USA). Electronic 
data are stored in a folder with restricted access on a 
protected server of the University Hospital Augsburg. 
Paper- based data are stored in a locked office at the study 
site.
Access to the original data and the pseudonymisa-
tion lists is restricted to employees of the Department 
of General and Transplant Surgery of the University 
Hospital Augsburg. The data will be deleted as soon 
as they are no longer used for research projects at the 
University Hospital Augsburg.
Pseudonymised quality of life data will be shared 
with researchers from University of Copenhagen and 
the EORTC with the purpose of statistical analysis of 
the customised EORTC quality of life questionnaire. A 
transfer of patient- related data to other institutions or 
companies does not take place.
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The VR software collects anonymous usage data (eg, 
frequency of use, duration of use and type of selected 
relaxation exercise) and two anonymous questions of 
well- being and forwards them to third- party companies. 
Since the VR headsets are also being used outside the 
study, external companies are not aware whether the 
headset is being used by study participants, hospital staff, 
other patients or other persons. There is no input or 
transmission of further data, in particular no disclosure 
of data that could give an indication of the identity of the 
current user.
Planned analysis
Continuous data will be presented as mean±SD or median 
with IQR, depending on distribution. Categorical data 
will be presented as numbers with percentages. Approx-
imately normally distributed continuous variables will be 
compared using the independent t- test. Non- normally 
distributed continuous variables will be compared 
using the Mann- Whitney U test. Categorical data will be 
compared using the χ2 test. Fisher’s exact test will be used 
for categorical data when the requirements for χ2 test were 
not met. A two- sided p<0.05 will be considered significant. 
The QLQ- C30 questionnaire will be scored according the 
EORTC QLQ- C30 scoring manual, and the short forms 
will be scored using the EORTC short form scoring soft-
ware.40 Repeated measurements analysis of variance is 
used to evaluate changes in quality of life measures and 
changes in vital signs during the study period.
Patient and public involvement statement
No patient involved.
Ethics approval and dissemination
The study protocol, the patient information and the 
informed consent form have been approved by the 
ethics committee of the Ludwigs- Maximilians- University, 
Munich, Germany (Reference Number: 19–915) and by 
the legal department of the University Hospital Augs-
burg, Germany.
We plan to publish the findings in peer- reviewed jour-
nals and share our findings at academic conferences.
Trial registration and trial status
A WHO Universal Trial Number (U1111-1242-6074) has 
been obtained. The trial has been prospectively registered 
at the German Clinical Trials Register (DRKS00020909). 
The trial is currently open for recruitment.
DISCUSSION
Improving quality of life and well- being for patients 
with cancer is one of the main goals for every caregiver 
involved in cancer treatment. The high prevalence of 
psychological distress, anxiety and depression in patients 
with cancer undergoing surgical or medical treatment 
is a call for action.2 6 7 Unfortunately, in many health-
care systems, a shortage of staff and financial resources 
often prevent a more holistic treatment that goes beyond 
pharmacological or surgical treatment. VR- based inter-
ventions are emerging in many different fields in medi-
cine because they are non- invasive, easy to apply and 
often cost- effective especially when compared with 
interventions that require more medical personnel and 
equipment. VR- based interventions using head- mounted 
devices can be performed at any location and without 
the need for scheduled appointments thereby poten-
tially offering a greater degree of flexibility for patients 
than traditional stress reduction interventions. Anxiety 
disorders and depression have been successfully treated 
using VR applications, and VR has shown to effectively 
distract patients during painful procedures resulting in 
less perceived pain and a more pleasant experience.32 33 37 
A recent review suggests that VR- based emotion regula-
tion training have a favourable influence on well- being.30 
Currently, there are no data regarding the perioperative 
use of VR- based interventions for perioperative stress 
reduction and relaxation. Therefore, we initiated a pilot 
study in order to investigate the usefulness and feasibility 
of a VR- based meditation intervention for perioperative 
stress reduction. Since EORTC data have shown that a 
significant number of patients with colorectal carcinoma 
suffer from depressive symptoms, sleep disorders, fatigue 
and a reduced quality of life, we have chosen to focus on 
this patient population.17
The three- arm randomised design of this this study has 
been chosen for two reasons. First, a standard two- arm 
design comparing a control group versus a VR group 
neglects the possibility that the additional attention and 
more frequent visits from medical personnel related to 
the intervention might be a strong bias. More contact 
with caregivers during the hospital stay might elicit the 
feeling of improved medical care and thereby already 
improve quality of life and patient satisfaction. We also 
took into consideration that other relaxing activities such 
listening to calming music might be equally effective 
thereby rendering a more expensive intervention unnec-
essary. We recognise this in our pilot trial by choosing a 
three- arm design.
The proposed pilot trial will be a first step in assessing 
the feasibility of VR- based interventions in the perioper-
ative phase and with the ultimate goal to improve patient 
care for patients with cancer.
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